Continuous Glucose Monitoring and the Opportunities for Optimal Diabetes Care and Cost Management
Reserve your spot today for the Satellite Lunch Symposium
Continuous Glucose Monitoring and the Opportunities for Optimal Diabetes Care and Cost Management

Jointly provided by Impact Education, LLC and Medical Education Resources, Inc.

Impact Education, LLC     Medical Education Resources
This activity is supported by an independent educational grant from Dexcom.
Tuesday, October 29, 2019
11:00 AM - 12:30 PM
Gaylord National Resort & Convention Center
Room: National Harbor 4-5
National Harbor, MD

Please note: Registration for AMCP Nexus 2019 is not required to attend this symposium.

Click Here to Download the Slides from this Symposium

To complete the evaluation and claim credit, please visit and use the code provided at the symposium. After submitting your evaluation instructions to claim CPE credit and submit to CPE Monitor will be provided. Thank you!
  Learn About
  • Cutting edge and fast growing interventions such as real-time continuous glucose monitoring (CGM)
  • The value of therapeutic CGM in comprehensive disease management programming
  Expert Faculty Presenters
Osama S. Eisa, MD
Senior Medical Director
Cigna HealthSpring
Estay Greene, PharmD
Vice President, Pharmacy Services
Blue Cross Blue Shield of North Carolina
Anita Swamy, MD
Medical Director, Chicago Children's Diabetes Center
Associate Clinician, Lurie Children's
Assistant Professor of Pediatrics, Northwestern Feinberg School of Medicine
Douglas McKell, MS, MSc, PgC HEOR
Impact Education, LLC.
  Who Should Attend?

This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of the AMCP, and other managed health care professionals attending the AMCP Nexus 2019 Meeting.

  Statement of Need/Program Overview

The vast majority of plan members with diabetes have an A1C above ADA targets, putting them at risk for other costly comorbidities. To effectively address these clinical challenges and elicit improvements across 29 indices of glycemic control and glycemic variability, continuous glucose monitoring (CGM) has been endorsed by various professional endocrinology-centered organizations. In 2017, the Centers for Medicare and Medicaid Services (CMS) Medicare made a milestone ruling, establishing benefit coverage for “therapeutic” CGM — a designation applying to those CGM systems approved for use in making treatment decisions without a fingerstick (“non-adjunctive use”). This program will elucidate the burden of diabetes and describe multifaceted clinical and administrative strategies across the medical and pharmacy benefits to promote quality care and manage costs while improving outcomes for affected plan members.

  Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Characterize the clinical and economic burden of diabetes in terms of health care resource utilization, indirect costs, and member quality of life
  • Describe the value of appropriate, evidence-based clinical interventions for managing morbidity and minimizing direct expenditures in other categories
  • Review the available consensus recommendations regarding evidence-based care in the management of diabetes
  • Characterize the role and value of CGM as part of a comprehensive diabetes management strategy
  • Discuss the adverse effect of specific benefit design schema and excess cost-sharing on patient access and adherence to clinical interventions
  • Employ pharmacy and medical benefit design strategies that account for the heterogeneity of patient populations and optimize outcomes

Date and Time
Tuesday, October 29, 2019
11:00 AM - 12:30 PM
Gaylord National Resort & Convention Center
Room: National Harbor 4-5
National Harbor, MD

11:00 AM Pre-Activity Learning Assessment and Opening Comments/Overview
Douglas McKell, MS, MSc, PgC HEOR
11:05 AM Evidence-based Diabetes Management and Monitoring Recommendations
Anita Swamy, MD
11:25 AM Q&A Session
11:30 AM The Value of Glucose Monitoring Systems as Part of a Comprehensive Management Strategy
Osama S. Eisa, MD
11:50 AM Pharmacy Benefit Management Strategies to Enhance Outcomes through Appropriate Coverage of CGM and Other Technology Interventions
Estay Greene, PharmD
12:20 PM Audience Q&A Session
12:25 PM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
12:30 PM Adjournment

  Accreditation Statements

Physician Credit
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Medical Education Resources, Inc. (MER) and Impact Education, LLC. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Medical Education Resources, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacy Credit
Medical Education Resources, Inc. (MER) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MER designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: 0816-9999-19-140-L01-P
This activity is certified as Knowledge-based CPE.

Disclosure of Conflicts of Interest
It is the policy of Medical Education Resources, Inc. to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis.

Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CME/CPE activity.
Registration for AMCP Nexus 2019 is not required to attend this symposium.

Pre-registration will close at 12:00 pm on October 28, 2019.
Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email